Annual Acute Hematologic Malignancies Symposium
Date: Nov. 2, 2019
Location: BCM Main – DeBakey Auditorium RM M12
Baylor St. Luke's Medical Center and the Dan L Duncan Comprehensive Cancer Center will bring together recognized national and international speakers to address recent advances in the diagnosis of myelodysplastic syndrome (MDS) and measurable residual disease [MRD] directed acute myelogenous leukemia (AML) therapy.
Gustavo A. Rivero, M.D.
- Assistant Professor
- (713) 798-3750
Martha Pritchett Mims, M.D., Ph.D.
- Professor and Chief
- (713) 798-7535
Dr. Martha Mims treats patients with hematologic malignancies and solid tumors.
C. Kent Osborne, M.D.
- (713) 798-1999
Diagnosis and treatment of breast cancer; Biology of breast cancer; Resistance to ER and HER2-targeted therapies in breast cancer…